As the precision medicine field continues to evolve at lightning speed, from next-gen ADCs and CGT drug-diagnostics to novel CNS and rare disease biomarkers, this year's milestone forum is your chance to discover the latest clinical case studies, global regulatory shifts, and harmonized commercialization strategies shaping the future of personalized care.

With brand-new data, case studies, and global perspectives, the 15th World Clinical Biomarkers & Companion Diagnostics Summit will span three tracks of content, shining the spotlight on:

• Biomarker Discovery & Translational Development: Exploring dynamic tumor profiling, functional and cell-based biomarker validation, and digital biomarkers in CNS and infectious disease
• Clinical Biomarker Development: Advancing biomarker strategies in cell and gene therapies, integrating liquid biopsy and extracellular vesicle analysis, and executing global trials
• CDx Development & Commercialization: Developing fit-for-purpose CDx strategies, navigating reimbursement/payer value frameworks, and optimizing launch planning

Plus, expect to hear keynote sessions on AI advances, digital pathology, LDT and IVDR regulation, global access, ADC drug-diagnostics, and co-development partnerships.